Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director comp.
Consulting agrmnt
Director departure
Quarterly results
Appointed director
CC transcript
Inv. presentation

MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/04/2018 4/A Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 513 restricted stock units @ $0
04/04/2018 4/A MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 513 restricted stock units @ $0
04/03/2018 4 Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 513 restricted stock units @ $0
04/03/2018 4 MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 513 restricted stock units @ $0
04/03/2018 4 Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 513 restricted stock units @ $0
04/03/2018 4 MAFFUID PAUL W (EXEC. VP, R AND D) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 1,735 shares @ $0
Exercised 5,015 restricted stock units @ $0
04/03/2018 4 HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 2,428 shares @ $0
Exercised 7,021 restricted stock units @ $0
04/03/2018 4 HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Paid exercise price by delivering 4,689 shares @ $0
Exercised 13,561 restricted stock units @ $0
02/23/2018 4 Resnick Paul F (VICE PRESIDENT, CBO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 80,000 options to buy @ $2.04, valued at $163.2k
02/23/2018 4 MAFFUID PAUL W (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 195,000 options to buy @ $2.04, valued at $397.8k
02/23/2018 4 HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 195,000 options to buy @ $2.04, valued at $397.8k
02/23/2018 4 HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 290,000 options to buy @ $2.04, valued at $591.6k
02/23/2018 4 Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 35,000 options to buy @ $2.04, valued at $71.4k
02/23/2018 4 EISENBERG JEFFREY F (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 35,000 options to buy @ $2.04, valued at $71.4k
02/23/2018 4 Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 35,000 options to buy @ $2.04, valued at $71.4k
02/23/2018 4 MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 35,000 options to buy @ $2.04, valued at $71.4k
02/23/2018 4 Livingston Philip O. (CHIEF SCIENCE OFFICER) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Granted 35,000 options to buy @ $2.04, valued at $71.4k
01/24/2018 4 EISENBERG JEFFREY F (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 17,444 shares @ $0.87, valued at $15.2k
Sold 17,998 shares @ $0.84, valued at $15.1k
01/24/2018 4 Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 17,445 shares @ $0.87, valued at $15.2k
Sold 17,996 shares @ $0.84, valued at $15.1k
01/24/2018 4 MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 17,449 shares @ $0.87, valued at $15.2k
Sold 17,999 shares @ $0.84, valued at $15.1k
01/24/2018 4 Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 17,444 shares @ $0.87, valued at $15.2k
Sold 17,996 shares @ $0.84, valued at $15.1k
01/18/2018 4 MAFFUID PAUL W (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 38,054 shares @ $0.92, valued at $35k
01/18/2018 4 HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 59,263 shares @ $0.92, valued at $54.5k
01/18/2018 4 Resnick Paul F (VICE PRESIDENT, CBO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 3,071 shares @ $0.92, valued at $2.8k
01/18/2018 4 HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 41,873 shares @ $0.92, valued at $38.5k
01/16/2018 4 HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 66,550 shares @ $0.96, valued at $63.9k
Sold 38,697 shares @ $0.98, valued at $37.9k
Sold 11,232 shares @ $0.96, valued at $10.8k
Exercised 449,159 restricted stock units @ $0
01/16/2018 4 Resnick Paul F (VICE PRESIDENT, CBO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 4,879 shares @ $0.96, valued at $4.7k
Sold 2,837 shares @ $0.98, valued at $2.8k
Sold 824 shares @ $0.96, valued at $791
Exercised 29,944 restricted stock units @ $0
01/16/2018 4 Livingston Philip O. (CHIEF SCIENCE OFFICER) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 21,155 shares @ $0.96, valued at $20.3k
Sold 12,301 shares @ $0.98, valued at $12.1k
Sold 3,571 shares @ $0.96, valued at $3.4k
Exercised 100,000 restricted stock units @ $0
01/16/2018 4 MAFFUID PAUL W (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 60,478 shares @ $0.96, valued at $58.1k
Sold 35,166 shares @ $0.98, valued at $34.5k
Sold 10,207 shares @ $0.96, valued at $9.8k
Exercised 406,382 restricted stock units @ $0
01/16/2018 4 HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Sold 110,093 shares @ $0.96, valued at $105.7k
Sold 64,015 shares @ $0.98, valued at $62.7k
Sold 18,582 shares @ $0.96, valued at $17.8k
Exercised 727,210 restricted stock units @ $0
01/12/2018 4 Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 100,000 restricted stock units @ $0
01/12/2018 4 Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 100,000 restricted stock units @ $0
01/12/2018 4 EISENBERG JEFFREY F (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 100,000 restricted stock units @ $0
01/12/2018 4 MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.
Txns: Exercised 100,000 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy